ArticleAntibiotics (Basel, Switzerland)2022

Off-Label Use of Dalbavancin for Sequential Treatment of Spondylodiscitis by Methicillin-Resistant

Maria Mazzitelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.